Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else? - Wikidata - awgldk - TriplyDB

Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else?

Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else?

http://www.wikidata.org/entity/Q52562630

about

Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else?

http://www.wikidata.org/entity/Q52562630

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else?

@en

Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else?

@nl

type

label

Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else?

@en

Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else?

@nl

prefLabel

Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else?

@en

Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else?

@nl

P1433

Q52562630-1F1FD1AD-DDBA-4EA3-A386-9BD7A400022B

P1476

Q52562630-2DDBCAC5-266F-4052-948B-8D69AF9905D7

P2093

Q52562630-7D836D45-3B57-4D25-AB83-0478CCBE1533

Q52562630-B198C74A-D3BC-4030-8733-5FBAAAEB5118

P2860

Q52562630-09BC6DCC-463E-47E5-9E16-70DEB9B95032

Q52562630-0C210363-2B09-4325-9F4E-45327F89ECA9

Q52562630-1119C6F2-EC27-4B93-851F-099E54AAD942

Q52562630-1593D6FD-0210-4621-9616-B74A58E76A2E

Q52562630-16D253A9-065B-4A2D-9527-B35B41452C99

Q52562630-18F44B42-2E06-475E-9000-C4256AB3CAAC

Q52562630-1D36355D-8C36-45D4-A3BF-9B234DDF759B

Q52562630-203258CB-96E5-473E-AD68-129A219751D0

Q52562630-2158DC39-6DD9-4BD4-BBF4-3397A0B05B79

Q52562630-2521857A-8906-44AC-9D6C-B7E829785D3D

P304

Q52562630-69C3B8CB-A0EC-4B62-8D39-D060F4C15D7B

P31

Q52562630-2073CD38-4B8D-472E-8812-A770D07821AE

P356

Q52562630-C939FBE0-05F1-4751-80EA-F714317B5BE4

P433

Q52562630-9B62158C-CB31-43CA-9571-63953B044B96

P478

Q52562630-B01F84B8-9487-43AB-A87F-81B1DA84A790

P577

Q52562630-46B49A69-8859-4697-A929-CEE6A57A147E

P698

Q52562630-0620C590-9769-44F5-9A9B-632355A77EE2

P921

Q52562630-3F3338A3-56BF-4451-AECA-29B3E8700341

P932

Q52562630-56A6526F-7E12-4AA0-9844-FDD6F7CA77F4

P356

P1433

International journal of endocrinology and metabolism

P1476

Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else?

@en

P2093

Ewa Otto-Buczkowska

http://www.w3.org/2001/XMLSchema#string

Natalia Jainta

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents

Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus

Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy.

Pramlintide and the treatment of diabetes: a review of the data since its introduction.

The use of metformin in type 1 diabetes: a systematic review of efficacy.

Does metformin improve vascular health in children with type 1 diabetes? Protocol for a one year, double blind, randomised, placebo controlled trial.

Sodium glucose cotransporter 2 inhibitors as a new treatment for diabetes mellitus.

Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study.

Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm.

The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Preserves Endothelial Function in Mesenteric Arteries from Type 1 Diabetic Rats without Decreasing Plasma Glucose.

P304

e13008

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5812/IJEM.13008

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29696037

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

5903388

http://www.w3.org/2001/XMLSchema#string